What is the recommended treatment for postherpetic neuralgia?

Treatment of Postherpetic Neuralgia

For postherpetic neuralgia, initiate treatment with gabapentin (300-3600 mg/d in divided doses), pregabalin (150-600 mg/d), or a tricyclic antidepressant like nortriptyline (25-150 mg/d at bedtime), with topical 5% lidocaine patches added for localized pain. 1

First-Line Pharmacological Approach

The treatment algorithm is straightforward and evidence-based 1:

Primary Options (Choose One to Start):

Calcium Channel α2-δ Ligands:

• Gabapentin: Start 300 mg once daily, titrate by 300 mg every 1-7 days up to 3600 mg/d in 3 divided doses. Requires 2 months for adequate trial 1
• Pregabalin: Start 150 mg/d in 2-3 divided doses, increase to 300 mg/d after 1-2 weeks. May provide faster relief than gabapentin. Maximum 600 mg/d, though higher doses show more adverse effects without consistent additional benefit 1

Tricyclic Antidepressants:

• Nortriptyline or desipramine (secondary amines preferred): Start 25 mg at bedtime, titrate by 25 mg weekly to 75-150 mg/d maximum 1
• Requires 6-8 weeks for adequate trial, including 2 weeks at highest tolerated dose 1
• Critical caveat: Obtain screening ECG for patients >40 years; use cautiously with cardiac disease; limit to <100 mg/d when possible 1

Topical Lidocaine 5% Patch:

• Apply up to 3 patches for maximum 12-18 hours daily 1
• Best for localized peripheral pain with allodynia 1
• Excellent tolerability with minimal systemic absorption—particularly advantageous in elderly patients 1
• Unlikely to benefit central neuropathic pain 1

When to Add or Switch Medications

If partial relief after adequate trial (pain remains ≥4/10): Add a second first-line medication from a different class 1

If <30% pain reduction at target dose: Switch to an alternative first-line medication 1

Goal: Reduce average pain to ≤3/10 with tolerable adverse effects 1

Second-Line Options for Acute Severe Pain or First-Line Failures

Tramadol:

• Start 50 mg once or twice daily, increase by 50-100 mg/d every 3-7 days
• Maximum 400 mg/d (300 mg/d if >75 years) 1
• Use as first-line only for: acute neuropathic pain, cancer-related pain, severe episodic exacerbations, or when rapid relief needed during first-line titration 1
• Warning: Lowers seizure threshold; can cause serotonin syndrome with SSRIs/SNRIs 1

Opioid Analgesics (morphine, oxycodone):

• Start morphine 10-15 mg every 4 hours or as needed
• Reserve for patients failing first-line therapies due to long-term safety concerns 1

Critical Treatment Principles

Timing matters: Earlier treatment initiation correlates with better pain control 2, 3. One study showed 79% success rate when disease duration <3 months versus 60% when ≥3 months 2

Combination therapy is superior to monotherapy 4. The strongest evidence supports combining gabapentin with topical lidocaine 4

Duloxetine and venlafaxine (SNRIs) are also first-line options per guidelines, though the evidence focuses more on other peripheral neuropathies 1

Common Pitfalls to Avoid

• Inadequate trial duration: Don't abandon gabapentin before 2 months or TCAs before 6-8 weeks 1
• Underdosing: Titrate to target doses unless limited by adverse effects
• Ignoring cardiac risk with TCAs: Always screen ECG in patients >40 years 1
• Using topical lidocaine for non-localized pain: It requires well-localized peripheral neuropathic pain to be effective 1

Special Considerations

For patients <60 years with chronic disease duration (≥6 months), consider suppressive valacyclovir 1000 mg/d for 12 months, which reduced pain scores and neuropathic medication requirements in recent high-quality evidence 5

Interventional procedures (epidural blocks, nerve blocks, plasma ablation) should be reserved for refractory cases failing pharmacological management 6, 4, 2